TrialDisease models & mechanisms2020

Pre-existing antibody-mediated adverse effects prevent the clinical development of a bacterial anti-inflammatory protein.

Angelino T Tromp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.